Long non-coding RNA modulator (Eli Lilly and Company/Haya Therapeutics)

N/A

Report date: 2024/10/25 11:50:10

Base Information

Drug NameLong non-coding RNA modulator (Eli Lilly and Company/Haya Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionRNA modulators
TargetsRibonucleic Acid
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHAYA Therapeutics SAEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesHAYA Therapeutics SAEli Lilly And Company
Inactive CompaniesN/A
Active IndicationsMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A